Berthy Al Mungiza
Bandung, West Java, 40161, Indonesia
Location status: Recruiting
Location contact
Berthy Al Mungiza, Bachelor
CONTACT
Vitriana Biben, Doctoral
CONTACT
NCT Number: NCT06574737
Hypothesis :
Based on the framework and premises above, the hypothesis is formulated as follows: H0 : surface electromyography parameters cannot predicts upper extremity motor function recovery in stroke patients H1: surface electromyography parameters can predicts upper extremity motor function recovery in stroke patients
Interested in participating?
Request Info18 year and older
All sexes
Observational
Bandung, West Java, 40161, Indonesia
Location status: Recruiting
Berthy Al Mungiza, Bachelor
CONTACT
Vitriana Biben, Doctoral
CONTACT
Study design and setting This study is an analytic quantitative observational study, to analyse the quantification of Manual Muscle Test score, Fugl Mayer Assessment-Upper Extremity score and electrical signals of the anterior deltoid, biceps, triceps, wrist flexors and wrist extensors muscles based on contractions, length of contraction and amplitude parameters in patients with acute phase stroke. This study performed at HasanSadikin Hospital between February 2024 - July 2024. Study participants Potential participants will be recruited by the main researcher
Inclusion criteria
Exclusion criteria
Drop out criteria:
Confounding factor:
Sampling Technique The method of sampling based on consecutive samplings, that is, all stroke patients who meet the inclusion and exclusion criteria during the duration of the study.
Based on the formula above, the minimum sample size for this research is adequate, so the minimum sample size is 30 samples.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 days of stroke onset, 5 days of stroke onset, 1 months, 2 months and 3 months after stroke onset
Time frame: 3 days of stroke onset, 5 days of stroke onset, 1 months, 2 months and 3 months after stroke onset
5: Normal 4: Good 3: Fair 2: Poor
1: Trace 0: Zero
(5 : higher end of strength ability, 0 = low-end ability of strength ability) (the more, the better outcome)
Time frame: 3 days of stroke onset, 5 days of stroke onset, 1 months, 2 months and 3 months after stroke onset
≤25 : severe 26-45 : moderate 46-66 : mild
(66 : maximum score for upper extremity score = normal, the more the better outcome)
Contact information is provided by the study sponsor or research team.
Berthy Al mungiza, Bachelor
CONTACT
Vitriana Biben, Doctoral
CONTACT
Universitas Padjadjaran
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05701280
Brain Diseases, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07598435
Brain Diseases, Cardiovascular Diseases
Faisalābad, Punjab Province, Pakistan
View Trial DetailsNCT06152328
Brain Diseases, Cardiovascular Diseases
Bolu, Merkez, Turkey (Türkiye)
View Trial DetailsNCT05515237
Brain Diseases, CVA (Cerebrovascular Accident)
Birmingham, Alabama, United States
View Trial Details